Reaching for specificity: X‐ray crystallographic data indicates potent 5α‐substituted swainsonine analogues bind in a novel fashion to Golgi α‐mannosidase II by inserting in a water cluster and by forming new hydrophobic interactions. These offer the potential of being extended into the GlcNAc binding site to improve selectivity and reduce harmful side effects.
达到特异性: X射线晶体学数据表明有效的5α-取代的swainsonine类似物通过插入
水簇中并形成新的疏
水性相互作用,以新颖的方式与高尔基
α-甘露糖苷酶II结合。这些提供了被扩展到GlcNAc结合位点以改善选择性和减少有害副作用的潜力。